• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Innate Pharma SA

+ Add to Watchlist

IPH:FP

7.9500 EUR 0.2500 3.05%

As of 11:35:00 ET on 07/11/2014.

Snapshot for Innate Pharma SA (IPH)

Open: 8.1400 Day's Range: 7.9000 - 8.4700 Volume: 472,560
Previous Close: 8.2000 52wk Range: 2.2400 - 12.3000 1-Yr Rtn: +235.44%

Stock Chart for IPH

No chart data available.
  • IPH:FP 7.9500
  • 1D
  • 1M
  • 1Y
8.2000
Interactive IPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.0700
Est. EPS (EUR) (12/2014) -0.2470
Est. PEG Ratio -
Market Cap (M EUR) 421.07
Shares Outstanding (M) 52.97
30 Day Average Volume 654,482
Price/Book (mrq) 9.0257
Price/Sale (ttm) 24.5121
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/17/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPH

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for IPH

Innate Pharma S.A. is a biopharmaceutical company. The Company develops first in class drugs that focus on cancer immunotherapy through the manipulation of the innate immune system.

Herve BraillyChairman-Mgmt Board/CEOMarcel RozencweigExec VP/Chief Medical Ofcr
Jerome TiollierExec VP/Chief Dev OfficerCatherine MoukheibirExec VP/Senior Advisor:Finance
More Company Profile & Key Executives for IPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil